TIL Instil Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 13, 2026
$7,22
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$5,67minimo 52 sett.
$21,98massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$49M
P/E
-0.7
EPS
$-10.70
i tuoi badge
Intervallo 52 sett.
$6–$22
Rating Analisti
BUY
Prezzo Obiettivo
$7
P/E
-0.7
ROE
-58.1%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
TIL Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$7.22
Capitalizzazione di Mercato (MRQ)
$49M
P/E
-0.7
EPS
$-10.70
ROE
-58.1%
Intervallo 52 sett.
$6–$22
TIL Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 08 Dicembre 2023 | 1-for-20 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi·2020-12-31 → 2021-12-31
EPS$-10.702020-12-31 → 2025-12-31
Flusso di cassa libero·2021-12-31 → 2024-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | TIL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.7media 5 anni ≈-46.9 | ≈-46.9 | · | · | |
| P/S | 941.7media 5 anni ≈9075.7 | ≈9075.7 | · | · | |
| P/B (MRQ) | 0.5media 5 anni ≈17.1 | ≈17.1 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -1.3media 5 anni ≈-75.1 | ≈-75.1 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.4media 5 anni ≈17.3 | ≈17.3 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | TIL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -30.6%media 5 anni ≈-33.8% | ≈-33.8% | -86.2% | Di prim'ordine | |
| ROE | -58.1%media 5 anni ≈-50.7% | ≈-50.7% | -111.1% | Di prim'ordine | |
| ROIC | -69.0%media 5 anni ≈-57.3% | ≈-57.3% | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | TIL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 21.7media 5 anni ≈18.0 | ≈18.0 | 2.5 | Liquidità elevata | |
| Quick Ratio | 1.4media 5 anni ≈7.1 | ≈7.1 | 1.8 | In linea |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-6.0%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 11, 2026 | $-0.63 | $-0.43 | -45.1% |
| 31 Marzo 2026 | Mag 15, 2026 | $-0.62 | $-0.60 | -4.0% |
| 31 Dicembre 2025 | $-1.21 | $-2.05 | 40.9% | |
| 30 Settembre 2025 | $-2.01 | $-2.38 | 15.5% | |
| 30 Giugno 2025 | $-3.24 | $-2.53 | -28.2% | |
| 31 Marzo 2025 | $-4.32 | $-2.61 | -65.3% | |
| 31 Dicembre 2024 | $-1.82 | $-3.25 | 44.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | $138.0K | |
| R&D Expense | · | · | $40M | $141M | $107M | $19M | |
| SG&A Expense | $27M | $44M | $48M | $62M | $48M | $14M | |
| Operating Expenses | $79M | $74M | $159M | $226M | $156M | $34M | |
| Operating Income | $-79M | $-74M | $-159M | $-226M | $-156M | $-34M | |
| Interest Expense | · | · | $5M | $2M | $0 | · | |
| Other Non-op | $212.0K | $-3M | $-575.0K | $-564.0K | $-1M | $-4M | |
| Pretax Income | $-71M | $-74M | $-156M | $-225M | $-157M | $-38M | |
| Income Tax | $0 | · | $0 | $-2M | $39.0K | $151.0K | |
| Net Income | $-71M | $-74M | $-156M | $-223M | $-157M | $-38M | |
| EPS (Basic) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| EPS (Diluted) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | $-2.36 | |
| Shares (Basic) | 6,668,268 | 6,510,138 | 6,503,913 | 6,475,631 | 105,993,230 | 15,997,794 | |
| Shares (Diluted) | 6,668,268 | 6,510,138 | 6,503,913 | 6,475,631 | 105,993,230 | 15,997,794 | |
| EBITDA | $-78M | $-70M | $-154M | $-220M | $-153M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $9M | $44M | $38M | $242M | |
| Short-term Investments | · | · | $141M | $217M | $417M | $0 | |
| Prepaid Expense | $3M | $9M | $9M | $8M | $10M | $4M | |
| Other Current Assets | $148.0K | $959.0K | $3M | · | · | $70.0K | |
| Current Assets | $191M | $124M | $161M | $269M | $464M | $246M | |
| PP&E (Net) | $126.0K | $129M | $139M | $197M | $122M | $55M | |
| PP&E (Gross) | $509.0K | $134M | $146M | $205M | $125M | $56M | |
| Accum. Depreciation | $383.0K | $5M | $8M | $8M | $3M | $306.0K | |
| Goodwill | · | · | · | $0 | $6M | $6M | |
| Other Non-current Assets | $4M | $4M | $639.0K | $3M | $8M | $2M | |
| Total Assets | $204M | $264M | $326M | $482M | $610M | $319M | |
| Accounts Payable | $779.0K | $659.0K | $1M | $2M | $6M | $3M | |
| Current Liabilities | $5M | $8M | $11M | $33M | $41M | $13M | |
| Capital Leases | $0 | $1M | $3M | $5M | $0 | · | |
| Deferred Tax | · | · | · | $0 | $2M | $2M | |
| Other Non-current Liabilities | $8.0K | $83.0K | $80.0K | $332.0K | $20.0K | $0 | |
| Total Liabilities | $90M | $94M | $100M | $119M | $55M | $27M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $841M | $825M | $807M | $789M | $757M | $6M | |
| Retained Earnings | $-726M | $-655M | $-581M | $-425M | $-202M | $-45M | |
| AOCI | $-583.0K | $-228.0K | $-348.0K | $-493.0K | $-87.0K | $-283.0K | |
| Stockholders' Equity | $114M | $169M | $226M | $364M | $555M | $-40M | |
| Liabilities + Equity | $204M | $264M | $326M | $482M | $610M | $319M | |
| Shares Outstanding | 6,781,976 | 6,525,887 | 6,503,913 | 6,503,913 | 6,451,463 | 20,591,554 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $534.0K | $4M | $5M | $6M | $3M | $256.0K | |
| Stock-based Comp | $9M | $17M | $18M | $30M | $26M | $2M | |
| Deferred Tax | · | · | $0 | $-2M | $39.0K | $267.0K | |
| Other Non-cash | $26M | $-2M | $51M | $9M | $6M | · | |
| Operating Cash Flow | $-37M | $-56M | $-82M | $-180M | $-122M | $-30M | |
| CapEx | · | $0 | $21M | $85M | $58M | $51M | |
| Investing Cash Flow | $25M | $54M | $41M | $115M | $-474M | $-51M | |
| Stock Issued | $7M | $0 | · | · | · | · | |
| Net Stock Activity | $7M | · | · | · | · | · | |
| Financing Cash Flow | $7M | $2M | $8M | $72M | $393M | $313M | |
| Free Cash Flow | · | $-56M | $-103M | $-265M | $-180M | · | |
| Levered FCF | · | · | $-108M | $-267M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -30.6% | -25.2% | -38.6% | -40.9% | -33.8% | · | |
| ROE | -58.1% | -42.9% | -67.9% | -57.6% | -27.1% | · | |
| ROIC | -69.0% | · | -70.5% | -61.7% | -28.0% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 39.5 | 15.8 | 15.2 | 8.2 | 11.2 | · | |
| Quick Ratio | 1.4 | 1.1 | 14.2 | 8.0 | 11.0 | · | |
| Interest Coverage | · | · | -30.6 | -120.3 | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.79 | $25.96 | $34.72 | $2.80 | $4.30 | · | |
| Revenue / Share | · | · | · | · | $0.00 | · | |
| Cash Flow / Share | $-5.49 | $-8.56 | $-12.61 | $-1.39 | $-1.15 | · | |
| Cash / Share | $0.98 | $1.35 | $1.41 | $0.34 | $0.29 | · | |
| EPS (TTM) | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $52.0K | $52.0K | $52.0K | $52.0K | $0 | · | |
| Net Income TTM | $-71M | $-74M | $-156M | $-223M | $-157M | · | |
| Market Cap | $75M | $125M | $50M | $1.64B | $44.15B | · | |
| P/E | -1.0 | -1.7 | -0.3 | -0.4 | -231.2 | · | |
| P/S | 1434.6 | 2395.8 | 953.1 | 31519.2 | · | · | |
| P/B | 0.7 | 0.7 | 0.2 | 4.5 | 79.5 | · | |
| P / Tangible Book | 0.7 | 0.7 | 0.2 | 4.5 | 80.4 | · | |
| P / Cash Flow | -2.0 | -2.2 | -0.6 | -9.1 | -361.5 | · | |
| P / FCF | · | -2.2 | -0.5 | -6.2 | -245.3 | · | |
| Earnings Yield | -97.3% | -59.7% | -315.0% | -273.5% | -0.43% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | $3M | $7M | · | $8M | $8M | $21M | $21M | $40M | |
| SG&A Expense | $5M | $5M | $6M | $6M | $6M | $9M | $10M | $11M | $11M | $12M | $11M | $12M | $12M | $13M | $13M | $17M | |
| Operating Expenses | $6M | $7M | $10M | $15M | $23M | $31M | $12M | $24M | $14M | $24M | $13M | $67M | $21M | $58M | $57M | $57M | |
| Operating Income | $-6M | $-7M | $-10M | $-15M | $-23M | $-31M | $-12M | $-24M | $-14M | $-24M | $-13M | $-67M | $-21M | $-58M | $-57M | $-57M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $2M | $590.0K | $636.0K | $745.0K | $807.0K | |
| Other Non-op | $-10.0K | $-182.0K | $-55.0K | $-118.0K | $342.0K | $43.0K | $-1M | $-530.0K | $-702.0K | $-428.0K | $-120.0K | $-1M | $628.0K | $-57.0K | $1M | $-415.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-13M | $-67M | $-19M | $-57M | $-54M | $-57M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-605.0K | $-371.0K | |
| Net Income | $-4M | $-4M | $-8M | $-14M | $-21M | $-28M | $-12M | $-23M | $-15M | $-24M | $-13M | $-67M | $-19M | $-57M | $-54M | $-56M | |
| EPS (Basic) | $-0.63 | $-0.62 | $-1.13 | $-2.01 | $-3.24 | $-4.32 | $-1.82 | $-3.54 | $-2.29 | $-3.74 | $-1.99 | $-10.37 | $-2.87 | $-8.77 | $-33.15 | $-0.43 | |
| EPS (Diluted) | $-0.63 | $-0.62 | $-1.13 | $-2.01 | $-3.24 | $-4.32 | $-1.82 | $-3.54 | $-2.29 | $-3.74 | $-1.99 | $-10.37 | $-2.87 | $-8.77 | $-33.15 | $-0.43 | |
| Shares (Basic) | 6,781,976 | 6,781,976 | · | 6,757,742 | 6,596,975 | 6,532,658 | · | 6,506,681 | 6,503,913 | 6,503,913 | · | 6,503,913 | 6,503,913 | 6,503,913 | · | 129,680,217 | |
| Shares (Diluted) | 6,781,976 | 6,781,976 | · | 6,757,742 | 6,596,975 | 6,532,658 | · | 6,506,681 | 6,503,913 | 6,503,913 | · | 6,503,913 | 6,503,913 | 6,503,913 | · | 129,680,217 | |
| EBITDA | $-6M | $-7M | · | $-15M | $-23M | $-30M | · | $-24M | $-14M | $-23M | · | $-67M | $-21M | $-57M | · | $-57M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $5M | $7M | $6M | $8M | $15M | $9M | $7M | $7M | $5M | $9M | $9M | $22M | $27M | $44M | $41M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $174M | $180M | $196M | $217M | $262M | |
| Prepaid Expense | $2M | $2M | $3M | $4M | $3M | $3M | $9M | $12M | $6M | $6M | $9M | $11M | $12M | $9M | $8M | $10M | |
| Other Current Assets | $76.0K | $143.0K | $148.0K | $164.0K | $154.0K | $192.0K | $959.0K | $2M | · | · | $3M | · | · | · | · | · | |
| Current Assets | $72M | $188M | $191M | $196M | $207M | $219M | $124M | $133M | $155M | $161M | $161M | $196M | $221M | $240M | $269M | $314M | |
| PP&E (Net) | $112M | $112.0K | $126.0K | $138.0K | $150.0K | $162.0K | $129M | $130M | $133M | $134M | $139M | $139M | $181M | $180M | $197M | $185M | |
| PP&E (Gross) | $112M | · | $509.0K | $509.0K | $509.0K | $509.0K | $134M | $134M | $138M | $138M | $146M | $146M | $187M | $185M | $205M | $191M | |
| Accum. Depreciation | $638.0K | $389.0K | $383.0K | $371.0K | $359.0K | $347.0K | $5M | $4M | $5M | $4M | $8M | $6M | $6M | $5M | $8M | $6M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $11M | $10M | $4M | $6M | $581.0K | $2M | $639.0K | $3M | $3M | $4M | $3M | $5M | |
| Total Assets | $198M | $200M | $204M | $212M | $231M | $237M | $264M | $273M | $294M | $306M | $326M | $340M | $408M | $427M | $482M | $533M | |
| Accounts Payable | $795.0K | $793.0K | $779.0K | $928.0K | $523.0K | $286.0K | $659.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $5M | |
| Current Liabilities | $3M | $5M | $5M | $6M | $14M | $7M | $8M | $10M | $10M | $11M | $11M | $13M | $18M | $27M | $33M | $42M | |
| Capital Leases | $2M | · | $0 | $0 | $6.0K | $48.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $555.0K | |
| Other Non-current Liabilities | $0 | $8.0K | $8.0K | $88.0K | $90.0K | $85.0K | $83.0K | $8.0K | $8.0K | $43.0K | $80.0K | $115.0K | $162.0K | $196.0K | $332.0K | $375.0K | |
| Total Liabilities | $90M | $90M | $90M | $91M | $99M | $93M | $94M | $96M | $99M | $100M | $100M | $106M | $112M | $116M | $119M | $122M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $843M | $842M | $841M | $839M | $837M | $829M | $825M | $820M | $816M | $812M | $807M | $803M | $798M | $794M | $789M | $782M | |
| Retained Earnings | $-735M | $-731M | $-726M | $-718M | $-705M | $-683M | $-655M | $-643M | $-620M | $-605M | $-581M | $-568M | $-501M | $-482M | $-425M | $-371M | |
| AOCI | $-587.0K | $-532.0K | $-583.0K | $-612.0K | $-805.0K | $-451.0K | $-228.0K | $-520.0K | $-627.0K | $-563.0K | $-348.0K | $-525.0K | $-795.0K | $-406.0K | $-493.0K | $-335.0K | |
| Stockholders' Equity | $107M | $111M | $114M | $120M | $132M | $145M | $169M | $176M | $195M | $206M | $226M | $234M | $297M | $311M | $364M | $411M | |
| Liabilities + Equity | $198M | $200M | $204M | $212M | $231M | $237M | $264M | $273M | $294M | $306M | $326M | $340M | $408M | $427M | $482M | $533M | |
| Shares Outstanding | 6,781,976 | 6,781,976 | 6,781,976 | 6,781,976 | 6,750,716 | 6,558,927 | 6,525,887 | 6,525,266 | 6,503,913 | 6,503,913 | 6,503,913 | 130,079,097 | 130,079,097 | 130,079,097 | 6,503,913 | 129,753,672 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $248.0K | $12.0K | $12.0K | $12.0K | $12.0K | $498.0K | $741.0K | $901.0K | $975.0K | $993.0K | $1M | $953.0K | $991.0K | $2M | $2M | $2M | |
| Stock-based Comp | $1M | $985.0K | $2M | $2M | $2M | $3M | $5M | $4M | $4M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | |
| Other Non-cash | · | $2M | · | · | · | $20M | · | · | · | $4M | · | · | · | $16M | · | · | |
| Operating Cash Flow | $-5M | $-1M | $-7M | $-11M | $-15M | $-4M | $-11M | $-20M | $-11M | $-14M | $-13M | $-14M | $-20M | $-35M | $-37M | $-41M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $58.0K | $5M | $7M | $8M | $13M | $25M | |
| Investing Cash Flow | $5M | $-317.0K | $8M | $8M | $-400.0K | $10M | $13M | $20M | $12M | $9M | $14M | $2M | $10M | $15M | $33M | $25M | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $0 | $0 | $378.0K | $7M | $232.0K | $2M | $159.0K | $0 | $0 | $0 | $-587.0K | $4M | $4M | $6M | $15M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-43M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-44M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -2.0% | -1.9% | · | -5.6% | -8.2% | -10.4% | · | -7.5% | -4.2% | -6.6% | · | -15.4% | -3.8% | -11.5% | · | -9.5% | |
| ROE | -3.6% | -3.3% | · | -9.2% | -13.1% | -16.1% | · | -11.2% | -6.1% | -9.4% | · | -20.9% | -4.9% | -13.9% | · | -11.1% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | -28.5% | -7.1% | -18.8% | · | -13.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | 39.9 | · | 34.5 | 15.0 | 30.3 | · | 12.9 | 15.1 | 14.2 | · | 14.5 | 12.0 | 9.0 | · | 7.5 | |
| Quick Ratio | 1.7 | 1.1 | · | 1.0 | 0.6 | 2.1 | · | 0.6 | 0.7 | 0.5 | · | 13.6 | 11.0 | 8.4 | · | 7.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -12.1 | · | -33.3 | -35.6 | -91.9 | · | -70.2 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.83 | $16.32 | · | $17.76 | $19.50 | $22.09 | · | $27.02 | $29.98 | $31.65 | · | $1.80 | $2.28 | $2.39 | · | $3.16 | |
| Cash Flow / Share | · | $-0.20 | · | · | · | $-0.64 | · | · | · | $-2.21 | · | · | · | $-0.27 | · | · | |
| Cash / Share | $0.82 | $0.74 | · | $0.86 | $1.14 | $2.34 | · | $1.02 | $1.04 | $0.84 | · | $0.07 | $0.17 | $0.21 | · | $0.32 | |
| EPS (TTM) | $-4.39 | $-7.00 | · | $-11.39 | $-12.92 | $-11.97 | · | $-11.56 | $-18.39 | $-18.97 | · | $-55.16 | $-45.22 | $-42.81 | · | $-1.53 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-30M | $-47M | · | $-75M | $-85M | $-78M | · | $-75M | $-120M | $-123M | · | $-197M | $-186M | $-226M | · | $-225M | |
| Market Cap | $52M | $56M | · | $121M | $141M | $114M | · | $439M | $67M | $70M | · | $1.11B | $1.43B | $1.72B | · | $12.56B | |
| P/E | -1.8 | -1.2 | · | -1.6 | -1.6 | -1.5 | · | -5.8 | -0.6 | -0.6 | · | -0.2 | -0.2 | -0.3 | · | -63.3 | |
| P/B | 0.5 | 0.5 | · | 1.0 | 1.1 | 0.8 | · | 2.5 | 0.3 | 0.3 | · | 4.8 | 4.8 | 5.5 | · | 30.6 | |
| P / Tangible Book | 0.5 | 0.5 | · | 1.0 | 1.1 | 0.8 | · | 2.5 | 0.3 | 0.3 | · | 4.8 | 4.8 | 5.5 | · | 31.0 | |
| P / Cash Flow | · | -41.8 | · | · | · | -27.1 | · | · | · | -4.9 | · | · | · | -49.6 | · | · | |
| Earnings Yield | -57.1% | -85.0% | · | -63.8% | -62.0% | -69.0% | · | -17.2% | -178.7% | -175.7% | · | -644.4% | -410.3% | -323.8% | · | -1.6% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | · | · | · | · | $0 |
| Utile netto | $-71M | $-74M | $-156M | $-223M | $-157M |
| EPS Diluito | $-10.70 | $-11.39 | $-24.00 | $-34.46 | $-1.48 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 39.5 | 15.8 | 15.2 | 8.2 | 11.2 |
| Quick Ratio | 1.4 | 1.1 | 14.2 | 8.0 | 11.0 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | $-56M | $-103M | $-265M | $-180M |
Proprietari istituzionali (13F) 31 filer · $35.2M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
31
Valore detenuto
$35.2M
Nuove posizioni
5
Posizioni chiuse
10
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 5 (-5 vs trimestre precedente) | 10 (+5 vs trimestre precedente) | 5 (+1 vs trimestre precedente) | 8 (0 vs trimestre precedente) | -394K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Curative Ventures V LLC | $14.603.341 | 1.899.004 | 41,45% | Azioni |
| BML Capital Management, LLC | $4.964.664 | 645.600 | 14,09% | Azioni |
| CPMG Inc | $3.385.997 | 410.922 | 9,61% | Azioni |
| Vivo Capital, LLC | $2.251.194 | 292.743 | 6,39% | Azioni |
| VANGUARD GROUP INC | $2.101.660 | 191.060 | 5,97% | Azioni |
| UBS Group AG | $1.364.383 | 177.423 | 3,87% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.259.145 | 163.738 | 3,57% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $1.034.882 | 134.575 | 2,94% | Azioni |
| Kalehua Capital Management LLC | $765.924 | 99.600 | 2,17% | Azioni |
| BlackRock, Inc. | $426.826 | 55.504 | 1,21% | Azioni |
| AlphaQuest LLC | $410.069 | 37.279 | 1,16% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $386.807 | 50.300 | 1,10% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $385.000 | 50.000 | 1,09% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $331.062 | 43.051 | 0,94% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $324.923 | 42.234 | 0,92% | Azioni |
| LPL Financial LLC | $246.653 | 32.075 | 0,70% | Azioni |
| CITADEL ADVISORS LLC | $235.614 | 30.639 | 0,67% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $175.124 | 22.773 | 0,50% | Azioni |
| STATE STREET CORP | $135.306 | 17.595 | 0,38% | Azioni |
| Americana Partners, LLC | $124.393 | 16.176 | 0,35% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $121.129 | 15.761 | 0,34% | Azioni |
| MORGAN STANLEY | $91.773 | 11.934 | 0,26% | Azioni |
| Pinpoint Asset Management Ltd | $88.432 | 5.094 | 0,25% | Azioni |
| Vanguard Global Advisers, LLC | $11.304 | 1.470 | 0,03% | Azioni |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $4.230 | 550 | 0,01% | Azioni |
| Lindbrook Capital, LLC | $1.180 | 68 | 0,00% | Azioni |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $961 | 125 | 0,00% | Azioni |
| CITIGROUP INC | $677 | 88 | 0,00% | Azioni |
| Tower Research Capital LLC (TRC) | $246 | 32 | 0,00% | Azioni |
| BARCLAYS PLC | $223 | 29 | 0,00% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $54 | 7 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Curative Ventures V LLC, CV-Immetacyte Manager LP, CV-Immetacyte Ultimate Manager LLC, SB2A LP, SB2A Management LLC, Bronson Crouch, Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power CVV 0 37,980,073 0 37,980,073 CV-Immetacyte Manager 0 37,980,073 0 37,980,073 Ultimate Manager 0 37,980,073 0 37,980,073 SB2A 0 40,380,072 0 40,380,072 SB2A Manager 0 40, Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power CVV 0 1,899,003 0 1,899,003 CV-Immetacyte Manager 0 1,899,003 0 1,899,003 Ultimate Manager 0 1,899,003 0 1,899,003 SB2A 0 2,019,002 0 2,019,002 SB2A Manager 0 2,019,002 ×2 depositi | 22 Ottobre 2024 | · | Deposito iniziale | · | SEC |
| CPMG, INC., R. KENT MCGAUGHY, JR. | 01 Aprile 2021 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 13 insider · 6 dirigenti · 7 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Bronson Crouch | CEO and Chairman | 25 Aprile 2025 A | 37.980.073 | 0 | 0 | $0 |
| Sandeep Laumas | CFO and CBO | 10 Settembre 2025 M | 0 | 0 | 0 | $0 |
| Timothy L. Moore | Chief Operating Officer | 06 Settembre 2022 A | · | 0 | 0 | $0 |
| Sumita Ray | Chief Legal and Admin Officer | 18 Gennaio 2023 A | · | 0 | 0 | $0 |
| Vijay Chiruvolu | Chief Technical Officer | 20 Maggio 2022 A | · | 0 | 0 | $0 |
| Zachary Roberts | Chief Medical Officer | 04 Marzo 2022 A | · | 0 | 0 | $0 |
| George Matcham | Direttore | 11 Giugno 2026 A | · | 0 | 0 | $0 |
| Gwendolyn Binder | Direttore | 11 Giugno 2026 A | · | 0 | 0 | $0 |
| Neil W Gibson | Direttore | 11 Giugno 2026 A | · | 0 | 0 | $0 |
| Kent R Mcgaughy Jr | Direttore | 11 Giugno 2026 A | 8.218.467 | 0 | 0 | $0 |
| Jack Nielsen | Direttore | 14 Giugno 2023 A | 12.486.787 | 0 | 0 | $0 |
| Nimish P Shah | Direttore | 23 Marzo 2021 C | 19.620 | 0 | 0 | $0 |
| Curative Ventures V LLC | Proprietario del 10% | 23 Marzo 2021 C | 37.980.073 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 6 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 12.764 SH | 11 Settembre 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,00% | 6.653 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1.000 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 41.589 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 118.992 SH | 19 Agosto 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 1.385 NS | 31 Luglio 2026 | N-PORT |
TIL Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 7 analisti
COMPRA
Target mediano
$7.00
-3,0%
2 28,6%
Acquisto forte
3 42,9%
Compra
2 28,6%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
1 analisti · 2026-10-04Target medio $7.00 -3,0%
Basso$7.00
Media$7.00
Alto$7.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 13, 2026